Standard and Interpretation
Recommendations for diagnosis and treatment of psoriatic arthritis in China
Su Yin, Wang Caihong, Gao Jinfang, Zhang Fengxiao, Lin Jinying, Zhang Liyun, Zhao Yan, on behalf of Chinese Rheumatology Association
Published 2022-08-01
Cite as Chin J Intern Med, 2022, 61(8): 883-892. DOI: 10.3760/cma.j.cn112138-20220103-00003
Abstract
Psoriatic arthritis is a chronic systemic autoimmune disease, characterized by psoriasis skin lesions and inflammation of the spine and joint. It has complicated clinical manifestations and individual variations. Nearly half of the patients will have joints erosion in two years, which is crippling. The severity of the skin and joint disease frequently do not correlate with each other. Currently, the understanding of the disease is insufficient in China with the lack of standardized diagnosis and treatment. Therefore, researchers from the Chinese Rheumatology Association formulated this specification based on the diagnosis and management experience together with guidelines at home and abroad. The specification summarizes the present situation of domestic diagnosis and treatment, aiming to standardize the diagnosis process and treatment protocols of psoriatic arthritis. Furthermore, it can reduce misdiagnosis and missed diagnosis, as well as improve the prognosis.
Key words:
Arthritis, psoriatic; Diagnosis; Treatment
Contributor Information
Su Yin
Department of Rheumatology and Immunology, Peking University People′s Hospital, Beijing 100044, China
Wang Caihong
Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China
Gao Jinfang
Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China
Zhang Fengxiao
Department of Rheumatology and Clinical Immunology, Hebei Provincal People′s Hospital, Shijiazhuang 050051, China
Lin Jinying
Department of Rheumatology and Immunology, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Zhang Liyun
Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China
Zhao Yan
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinial Immunology, Ministry of Education, Beijing 100730, China
on behalf of Chinese Rheumatology Association